Aug 2026· Technology in Cancer Research and Treatment· Vol 25, pp.
15330338261495691
· 0 citations· 47 references
Medicine
TL;DR
These findings offer candidate molecules associated with the transition from benign endometriosis to ovarian endometrioid carcinoma; however, further functional studies are required to determine whether they may actively drive malignant transformation.
Abstract
IntroductionEndometriosis (EMs) is considered the precursor lesions of ovarian endometrioid carcinoma (OEC). This study aimed to identify differentially expressed proteins between OEC and EMs, and to explore the associated biological functional alterations.Materials and MethodsThis study conducted qualitative and quantitative label-free proteomic analysis on postoperative formalin-fixed paraffin-embedded (FFPE) specimens from 20 patients with EMs and 54 patients with OEC coexisting with EMs. A discovery set was established based on cluster random sampling, and differentially expressed proteins between the two groups were progressively screened. The identified candidates were then validated in an independent test cohort, followed by external validation using public transcriptomic datasets (GSE295399, GSE105764, GSE281569) from the Gene Expression Omnibus (GEO) database.ResultsThe OEC group exhibited a distinct protein expression profile compared to the EMs group. Seven differentially expressed hub proteins (SNRPD1, HNRNPC, NOP58, SRSF6, DHX9, SF3B3, and DHX15) were identified from the discovery cohort, all of which showed significantly altered expression in the test cohort (p < 0.0001). External transcriptomic validation confirmed consistent upregulation for five of the seven hub proteins in OEC compared to EMs (NOP58, SRSF6, DHX9, SF3B3, and DHX15; p < 0.001).ConclusionThis study identified and validated seven differentially expressed proteins associated with RNA splicing in OEC relative to EMs. These findings offer candidate molecules associated with the transition from benign endometriosis to ovarian endometrioid carcinoma; however, further functional studies are required to determine whether they may actively drive malignant transformation.
In‑vitro experiments demonstrated that SLC12A8 modulates proliferation, invasion, and migration in both EM and EAOC cell lines, and support SLC12A8 as a candidate functional mediation and potential biomarker linked to EM‑EAOC pathological progression, thereby extending the mechanistic understanding of these disorders.
Background: Endometriosis is a known risk factor for ovarian clear cell carcinoma (OCCC). This study aimed to identify potential hub genes in fertile and infertile women with endometriosis and explore key biological pathways involved in disease progression. Materials and Methods: In this bioinformatics study, microarra...
Elnaz Zaefari, Zahra Noormohammadi, A. Moini et al.· International Journal of Fer...· 0 citations
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor in China, with a poor five-year survival rate due to the lack of effective early diagnostic methods. This study aimed to identify potential non-invasive biomarkers and clarify their underlying mechanisms.
We employed an integrative approac...
Wei-Zhong Chen, Shu-Lin Chen, Run-Kun Han et al.· Frontiers in Immunology· 0 citations
Background and Aim: Endometrial cancer is considered one of the most common cancers of the female genital system, with endometrioid endometrial carcinoma (EEC) being the most common subtype. Valosin-containing protein (VCP), or p97, acts as an important regulator of cellular protein homeostasis and is thought to play a...